NBY
$1.36
NovaBay Pharmaceuticals, Inc.
Intraday
Recent News
Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge
Event context and why NovaBay might be on your radar NovaBay Pharmaceuticals (NBY) has drawn attention recently as investors look at its current pricing and past returns to reassess the risk and potential reward profile of this wound care focused business. See our latest analysis for NovaBay Pharmaceuticals. The recent surge in NovaBay Pharmaceuticals' share price, including a 1 day share price return above 100% and a very large 1 year total shareholder return, follows a period where longer...
Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data
US stocks look set to open little changed Friday's trading session as investors look ahead to econom
NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. NovaBay Pharmaceuticals, Inc. is one of them. NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is a biopharmaceutical company specializing in anti-infective therapies for inflammation and infection-related conditions. Its flagship product, Avenova, is an antimicrobial lid and lash […]